Pacific Biosciences of California Inc (PACB) Testing Investors’ Patience Right Now
Currently, there are 267.74M common shares owned by the public and among those 259.95M shares have been available to trade. The company’s stock has a 5-day price change of -6.36% and 26.56% over the past three months. PACB shares are trading -83.49% year to date (YTD), with the 12-month market performance down to -80.60% lower. […]
Stick With Pacific Biosciences of California Inc (PACB). The Bull Are Alive And Well
Currently, there are 267.74M common shares owned by the public and among those 259.95M shares have been available to trade. The company’s stock has a 5-day price change of -5.95% and 20.00% over the past three months. PACB shares are trading -82.26% year to date (YTD), with the 12-month market performance down to -80.67% lower. […]
Growing Through Challenges? – Pacific Biosciences of California Inc (PACB)
Currently, there are 267.44M common shares owned by the public and among those 253.36M shares have been available to trade. Insiders at the company have transacted a total of 19 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (NASDAQ: PACB) – Suitable For Long Term Buy?
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
These Numbers Could Change Investor Views For Pacific Biosciences of California Inc (NASDAQ: PACB)
Currently, there are 267.44M common shares owned by the public and among those 256.44M shares have been available to trade. Insiders at the company have transacted a total of 21 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]
Pacific Biosciences of California Inc (PACB): Street Finally Waking Up
ARK Investment Management LLC recently announced the acquisition of new stake in Pacific Biosciences of California Inc (NASDAQ:PACB). The institutional investor has increased its shareholding in the Healthcare company by 15.70% to 34.5 million shares with purchase of 4.68 million shares. This fresh investment now brings its stake to 12.90% valued currently at $338.49 million. […]
Gains May Be On The Menu For Pacific Biosciences of California Inc (NASDAQ: PACB)
ARK Investment Management LLC recently announced the acquisition of new stake in Pacific Biosciences of California Inc (NASDAQ:PACB). The institutional investor has increased its shareholding in the Healthcare company by 15.70% to 34.5 million shares with purchase of 4.68 million shares. This fresh investment now brings its stake to 12.90% valued currently at $338.49 million. […]
Analyst Expect Big Moves From Pacific Biosciences of California Inc (NASDAQ: PACB)
ARK Investment Management LLC recently announced the acquisition of new stake in Pacific Biosciences of California Inc (NASDAQ:PACB). The institutional investor has increased its shareholding in the Healthcare company by 11.97% to 29.82 million shares with purchase of 3.19 million shares. This fresh investment now brings its stake to 11.15% valued currently at $252.89 million. […]
Better Times Ahead For Pacific Biosciences of California Inc (NASDAQ: PACB)?
ARK Investment Management LLC has recently announced that it has increased stake in Pacific Biosciences of California Inc (NASDAQ:PACB) by 11.97%. After grabbing 29.82 million shares, the institutional investor is now in possession of 3.19 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 11.15% having worth around […]
Better Times Ahead For Pacific Biosciences of California Inc (NASDAQ: PACB)?
ARK Investment Management LLC has recently announced that it has increased stake in Pacific Biosciences of California Inc (NASDAQ:PACB) by 11.97%. After grabbing 29.82 million shares, the institutional investor is now in possession of 3.19 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 11.15% having worth around […]
